Abstract:GPCRs (G-protein-coupled receptors) are versatile signalling molecules at the cell surface and make up the largest and most diverse family of membrane receptors in the human genome. They convert a large variety of extracellular stimuli into intracellular responses through the activation of heterotrimeric G-proteins, which make them key regulatory elements in a broad range of normal and pathological processes, and are therefore one of the most important targets for pharmaceutical drug discovery. Knowledge of a GPCR structure enables us to gain a mechanistic insight into its function and dynamics, and further aid rational drug design. Despite intensive research carried out over the last three decades, resolving the structural basis of GPCR function is still a major activity. The crystal structures obtained in the last 5 years provide the first opportunity to understand how protein structure dictates the unique functional properties of these complex signalling molecules. However, owing to the intrinsic hydrophobicity, flexibility and instability of membrane proteins, it is still a challenge to crystallize GPCRs, and, when this is possible, it is no longer in its native membrane environment and no longer without modification. Furthermore, the conformational change of the transmembrane a-helices associated with the structure activation increases the difficulty of capturing the activation state of a GPCR to a higher resolution by X-ray crystallography. On the other hand, solid-state NMR may offer a unique opportunity to study membrane protein structure, ligand binding and activation at atomic resolution in the native membrane environment, as well as described functionally significant dynamics. In the present review, we discuss some recent achievements of solid-state NMR for understanding GPCRs, the largest mammalian proteome at similar to 1% of the total expressed proteins. Structural information, details of determination, details of ligand conformations and the consequences of ligand binding to initiate activation can all be explored with solid-state NMR.

Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions

Structural insights into G-protein-coupled receptor allostery

Allosteric Coupling of Drug Binding and Intracellular Signaling in the A2A Adenosine Receptor

Structural insights into positive and negative allosteric regulation of a G protein-coupled receptor through protein-lipid interactions

Propagation of the Allosteric Modulation Induced by Sodium in the δ-Opioid Receptor.

Harnessing Ion-Binding Sites for GPCR Pharmacology

Communication over the network of binary switches regulates the activation of A$_{2A}$ adenosine receptor

Ligand modulation of sidechain dynamics in a wild-type human GPCR

Structural Basis of Orientated Asymmetry in a Mglu Heterodimer

Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface

G-Protein-Coupled Receptor Structure, Ligand Binding and Activation As. Studied by Solid-State Nmr Spectroscopy

Mechanism of Β 2 AR Regulation by an Intracellular Positive Allosteric Modulator

Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.

Structure and dynamics determine G protein coupling specificity at a class A GPCR

Structural and dynamic insights into supra-physiological activation and allosteric modulation of a muscarinic acetylcholine receptor

GPCR Allostery: A View from Computational Biology.

Anionic phospholipids control mechanisms of GPCR-G protein recognition

Structural insights into ligand recognition, activation, and signaling of the α 2A adrenergic receptor

Pharmacologically Targeting Intracellular Allosteric Sites of GPCRs for Drug Discovery.

Structure of the adenosine A2A receptor bound to an engineered G protein

Activation Pathway of a G Protein-Coupled Receptor Uncovers Conformational Intermediates As Targets for Allosteric Drug Design